Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Pharmacological Research

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1043-6618(03)00096-3PMID 12770514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular targets of lithium action.

  2003cited by this paper
• The Wnt Signaling Pathway in Bipolar Disorder

  2002cited by this paper
• 1α, 25-(OH)2-D3 and its synthetic analogue decrease tumor load in the Apcmin mouse

  2002cited by this paper
• Mood stabilizer psychopharmacology.

  2002cited by this paper
• Phosphorylation of Glycogen Synthase Kinase-3&bgr; During Preconditioning Through a Phosphatidylinositol-3-Kinase–Dependent Pathway Is Cardioprotective

  2002cited by this paper
• Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.

  2002cited by this paper
• Neuroprotective effects of lithium in cultured cells and animal models of diseases.

  2002cited by this paper
• 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse.

  2002cited by this paper
• Glycogen synthase kinase 3: an emerging therapeutic target.

  2002cited by this paper
• First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

  2002cited by this paper
• Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

  2002cited by this paper
• Treatment Research in Bipolar Disorder

  2002cited by this paper
• Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.

  2002cited by this paper
• The mechanism of lithium action: state of the art, ten years later.

  2001cited by this paper
• Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease.

  2001cited by this paper
• Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen*

  2001cited by this paper
• GSK3 takes centre stage more than 20 years after its discovery.

  2001cited by this paper
• Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.

  2001cited by this paper
• Glycogen synthase kinase-3: properties, functions, and regulation.

  2001cited by this paper
• 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

  2001cited by this paper
• Judging a Protein by More Than Its Name: GSK-3

  2001cited by this paper
• APC, Signal transduction and genetic instability in colorectal cancer

  2001cited by this paper
• Differential Dietary Effects on Colonic and Small Bowel Neoplasia in C57BL/6J Apc Min/+ Mice

  2001cited by this paper
• The renaissance of GSK3

  2001cited by this paper
• Disease model: familial adenomatous polyposis.

  2001cited by this paper
• The Mood Stabilizer Valproic Acid Activates Mitogen-activated Protein Kinases and Promotes Neurite Growth*

  2001cited by this paper
• Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death

  2001cited by this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cited by this paper
• The molecular bases of Alzheimer's disease and other neurodegenerative disorders.

  2001cited by this paper
• Linking colorectal cancer to Wnt signaling.

  2000cited by this paper
• Inadequate dietary copper increases tumorigenesis in the Min mouse.

  2000cited by this paper
• Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.

  2000cited by this paper
• Suicide and Bipolar Disorder

  2000cited by this paper
• The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3

  2000cited by this paper
• Enhancement of Hippocampal Neurogenesis by Lithium

  2000cited by this paper
• Beef induces and rye bran prevents the formation of intestinal polyps in Apc(Min) mice: relation to beta-catenin and PKC isozymes.

  2000cited by this paper
• Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling*

  2000cited by this paper
• Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

  2000cited by this paper
• Suicide and bipolar disorder.

  2000cited by this paper
• Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration.

  2000cited by this paper
• Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells.

  1999cited by this paper
• Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons.

  1999cited by this paper
• Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression

  1999cited by this paper
• The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS

  1999cited by this paper
• Lack of a recommended dietary allowance for copper may be hazardous to your health.

  1998cited by this paper
• Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment

  1998cited by this paper
• Mechanisms of Wnt signaling in development.

  1998cited by this paper
• Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats

  1998cited by this paper
• Wnt signaling: a common theme in animal development.

  1997cited by this paper
• Activation of the Wnt signaling pathway: a molecular mechanism for lithium action.

  1997cited by this paper
• Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons

  1997cited by this paper
• Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells.

  1996cited by this paper
• A molecular mechanism for the effect of lithium on development.

  1996cited by this paper
• Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Grow for the Study of Lithium‐Treated Patieits (IGSLI)

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis.

  1995cited by this paper
• Extended Survival of Patients on Long-Term Lithium Treatment

  1995cited by this paper
• A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.

  1994cited by this paper
• The effect of long‐term lithium treatment on the mortality of patients with manic‐depressive and schizoaffective illness *

  1992cited by this paper
• Familial Adenomatous Polyposis

  1992cited by this paper
• Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.

  1992cited by this paper
• Identification of FAP locus genes from chromosome 5q21.

  1991cited by this paper
• Identification and characterization of the familial adenomatous polyposis coli gene

  1991cited by this paper
• A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

  1990cited by this paper
• Lithium treatment in Aarhus. 1. Prevalence.

  1989cited by this paper
• The effect of lithium chloride on tumour appearance and survival of melanoma-bearing mice.

  1983cited by this paper
• Lithium carbonate in patients with small cell lung cancer receiving combination chemotherapy.

  1981cited by this paper
• Effect of alkali metal salts on sarcoma I in A/J mice

  1981cited by this paper
• The effect of lithium carbonate administration in patients with advanced small cell bronchogenic carcinoma receiving combination chemotherapy and radiotherapy.

  1980cited by this paper
• The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy.

  1980cited by this paper
• The medical literature. Let the reader beware.

  1980cited by this paper
• Lithium carbonate attenuation of chemotherapy-induced neutropenia.

  1977cited by this paper
• Effect of lithium carbonate on the neutropenia caused by chemotherapy: a preliminary clinical trial.

  1977cited by this paper

• Telomere dysfunction alters intestinal stem cell dynamics to promote cancer.

  2024cites this paper
• Development of a Biodegradable PLGA Carrier to Provide Wnt Agonists and Antibiotics to Meet the Requirements for Patients with Bone Infections

  2024cites this paper
• Colorectal cancer initiation: Understanding early-stage disease for intervention.

  2024cites this paper
• The CHAMP-study: the CHemopreventive effect of lithium in familial AdenoMatous Polyposis; study protocol of a phase II trial

  2022cites this paper
• Apc-mutant cells act as supercompetitors in intestinal tumour initiation

  2021cites this paper
• Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis

  2020cites this paper
• Glycogen Synthase Kinase 3β in Cancer Biology and Treatment

  2020cites this paper
• A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita

  2018cites this paper
• Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells

  2018cites this paper
• Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.

  2017cites this paper
• Replication analyses of four chromosomal deletions with schizophrenia via independent large‐scale meta‐analyses

  2016cites this paper
• Long-term use of lithium and risk of colorectal adenocarcinoma: a nationwide case–control study

  2016cites this paper
• PTEN Overexpression Cooperates With Lithium to Reduce the Malignancy and to Increase Cell Death by Apoptosis via PI3K/Akt Suppression in Colorectal Cancer Cells

  2016cites this paper
• Regenerating Reputations: Are Wnt and Myc the Good Guys After All?

  2016cites this paper
• FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β

  2015cites this paper
• FAK / PYK 2 promotes the Wnt / β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK 3 β

  2015cites this paper
• Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK‐3β‐dependent β‐catenin/Wnt pathway activation

  2014cites this paper
• Regulation of Inflammation and T Cells by Glycogen Synthase Kinase-3: Links to Mood Disorders

  2014cites this paper
• BCL9 and C9orf5 Are Associated with Negative Symptoms in Schizophrenia: Meta-Analysis of Two Genome-Wide Association Studies

  2013cites this paper
• A review of the evidence for the canonical Wnt pathway in autism spectrum disorders

  2012cites this paper
• Bipolar Bozukluk ve Kanser

  2012cites this paper
• Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models

  2012cites this paper
• Bipolar Bozukluk ve Kanser Bipolar Disorder and Cancer

  2012cites this paper
• Lithium Suppresses Astrogliogenesis by Neural Stem and Progenitor Cells by Inhibiting STAT3 Pathway Independently of Glycogen Synthase Kinase 3 Beta

  2011cites this paper
• Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.

  2011cites this paper
• Mechanisms of lithium ’ s neuroprotective actions 2 . 1 Lithium as a multi-functional neuroprotectant

  2011cites this paper
• Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment

  2011cites this paper
• Common variants in the BCL9 gene conferring risk of schizophrenia.

  2011cites this paper
• Regulation by Glycogen Synthase Kinase-3 of Inflammation and T Cells in CNS Diseases

  2011cites this paper
• The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseases.

  2011cites this paper
• Effect of lithium on smooth muscle contraction and phosphorylation of myosin light chain by MLCK.

  2010cites this paper
• Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

  2010cites this paper
• β‐Galactosidase enzyme fragment complementation for the measurement of Wnt/β‐catenin signaling

  2010cites this paper
• Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

  2010cites this paper
• Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease.

  2010cites this paper
• (cid:1) -Galactosidase enzyme fragment complementation for the measurement of Wnt/ (cid:1) -catenin signaling

  2010cites this paper
• Targeting protein kinases in central nervous system disorders

  2009cites this paper
• Abnormalities in brain structure and behavior in GSK-3alpha mutant mice

  2009cites this paper
• Review of Lithium Effects on Brain and Blood

  2009cites this paper
• Deregulated GSK3 Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase

  2009cites this paper
• An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta.

  2009cites this paper
• A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test.

  2009cites this paper
• Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer.

  2008cites this paper
• GSK-3 Inhibitors: A Ray of Hope for the Treatment of Alzheimer's Disease?

  2008cites this paper
• Preclinical efficacy on GSK‐3 inhibitors: Towards a future generation of powerful drugs

  2008cites this paper
• Inhibition of GSK‐3β activity attenuates proliferation of human colon cancer cells in rodents

  2007cites this paper
• Development of leiomyosarcoma of the uterus in MMTV‐CR‐1 transgenic mice

  2007cites this paper
• β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive Behaviors

  2007influential citation
• Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

  2007cites this paper
• Strain Differences in Lithium Attenuation of d-Amphetamine-Induced Hyperlocomotion: A Mouse Model for the Genetics of Clinical Response to Lithium

  2007cites this paper
• Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?

  2007cites this paper
• Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.

  2007cites this paper
• Targeting GSK-3: a promising approach for cancer therapy?

  2006cites this paper
• Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease.

  2006cites this paper
• Wnt signaling and gastrointestinal tumorigenesis in mouse models

  2006cites this paper
• The Wnt-dependent signaling pathways as target in oncology drug discovery

  2006cites this paper
• Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.

  2006cites this paper
• Glycogen synthase kinase-3--an overview of an over-achieving protein kinase.

  2006cites this paper
• Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications

  2006cites this paper
• GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid.

  2005cites this paper
• Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance.

  2005cites this paper
• Pharmacogenetics in mood disorder

  2005cites this paper
• Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs

  2005cites this paper
• Leptin secretion by human ejaculated spermatozoa.

  2005influential citation
• The nonsteroidal anti-inflammatory drug, nabumetone, differentially inhibits beta-catenin signaling in the MIN mouse and azoxymethane-treated rat models of colon carcinogenesis.

  2005cites this paper
• Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice.

  2005cites this paper
• Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.

  2004cites this paper
• Glycogen synthase kinase 3: a drug target for CNS therapies

  2004cites this paper
• GSK-3 inhibitors: discoveries and developments.

  2004cites this paper
• GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression.

  2004cites this paper
• Pharmacological inhibitors of glycogen synthase kinase 3.

  2004cites this paper
• Pharmacoepidemiological assessment of drug-cancer associations

  year unknowncites this paper